Skip to content

Kalifilcon A Toric Compared to Commercially Available Lenses

Orientation Characteristics of Kalifilcon A Daily Disposable Toric Contact Lenses Compared to Commercially Available Daily Disposable Toric Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06098937
Enrollment
30
Registered
2023-10-25
Start date
2023-09-05
Completion date
2023-09-27
Last updated
2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Keywords

Contact Lens

Brief summary

Approximately thirty contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study.

Detailed description

Approximately 30 soft toric contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If study eligibility is met, subjects will have lenses inserted in random, successive order. Subjects will be receiving each of the study lens types once, in a randomized order. The subject will wear each of the study contact lenses for approximately 10 minutes.

Interventions

DEVICEKalifilcon Toric Lens

Kalifilcon A Daily Disposable Toric for Ametropia

DEVICETotal1 for Astigmatism

Total1 for Astigmatism

Precision1 for Astigmatism

MyDay Toric

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Be 18 years or older on the date the Informed Consent Form (ICF) is signed and have capacity to read, understand and provide written voluntary informed consent. 2. Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings. 3. Have no active ocular disease or allergic conjunctivitis. 4. Not be using any topical ocular medications. 5. Be willing and able to follow instructions. 6. Have signed a statement of informed consent.

Exclusion criteria

1. Participating in a conflicting study in the opinion of the Investigator. 2. Considered by the Investigator to not be a suitable candidate for participation

Design outcomes

Primary

MeasureTime frameDescription
Primary Gaze Orientation for 5 Minutes5 minutes after lens insertionPrimary gaze orientation is measured in degrees using a slit lamp and reticule.

Countries

United States

Participant flow

Participants by arm

ArmCount
Kalifilcon A Daily Disposable Toric, Total1, Precision1, and MyDay Toric.
Participants received kalifilcon A daily disposable toric, Total1 for Astigmatism, Precision1 for Astigmatism, and MyDay Toric.
30
Total30

Baseline characteristics

CharacteristicKalifilcon A Daily Disposable Toric, Total1, Precision1, and MyDay Toric.
Age, Continuous
Age 28 to 70
46.6 years
STANDARD_DEVIATION 12.53
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
28 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
27 Participants
Region of Enrollment
United States
30 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Primary Gaze Orientation for 5 Minutes

Primary gaze orientation is measured in degrees using a slit lamp and reticule.

Time frame: 5 minutes after lens insertion

ArmMeasureValue (MEAN)Dispersion
Kalifilcon A Daily Disposable ToricPrimary Gaze Orientation for 5 Minutes3.3 degreesStandard Deviation 5.19
Total1 for AstigmatismPrimary Gaze Orientation for 5 Minutes2.8 degreesStandard Deviation 4.16
Precision1 for AstigmatismPrimary Gaze Orientation for 5 Minutes2.4 degreesStandard Deviation 3.96
MyDay ToricPrimary Gaze Orientation for 5 Minutes3.6 degreesStandard Deviation 5.45

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026